Current opinions on some transfusion reactions;Współczesne pogla̧dy na niektóre powikłania poprzetoczeniowe

Acta Haematologica Polonica

Volumn 40, Issue 2, 2009, Pages 407-423

  Łȩjowska, Magdalena ^a   Zupańska, Barbara ^a  

^a INSTITUTE OF HEMATOLOGY AND TRANSFUSION MEDICINE   (Poland)

Author keywords

Adverse reactions; Blood and blood components; Recipient; Transfusion reactions

Indexed keywords

BRADYKININ; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; THROMBOCYTE ANTIGEN;

BLOOD TRANSFUSION REACTION; CHILL; DISTRESS SYNDROME; DYSPNEA; FEBRILE NONHEMOLYTIC TRANSFUSION REACTION; FEVER; HUMAN; HYPOTENSION; IMMUNOLOGY; IMMUNOMODULATION; LIMB PAIN; LOW BACK PAIN; MEDICAL STAFF; PATIENT MONITORING; RASH; REVIEW; SKIN REDNESS; THROMBOCYTOPENIC PURPURA; TRANSFUSION ASSOCIATED CIRCULATORY OVERLOAD; TRANSFUSION RELATED ACUTE LUNG INJURY;

EID: 69249140266     PISSN: 00015814     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (36)

1. Łȩtowska M. (red.) Medyczne zasady pobierania krwi, oddzielania jej składników i wydawania, obowia̧zuja̧ce w jednostkach organizacyjnych publicznej słuiżby krwi. Warszawa, Instytut Hematologii i Transfuzjologii, 2006; 11-1-11-110
2. Ambruso DR.: Acute hemolytic transfusion reactions. W: Hillyer CD, Silberstein LE, Ness PM, Anderson KC.: Blood Banking and Transfusion Medicine-Basic principles and Practice. Churchill Livingstone, Philadelphia 2003; 391-395.
3. Haemolytic transfusion reactions.: W: Klein HG, Anstee DJ.: Mollison's Blood Transfusion in Clinical Medicine. Blackwell Publishing, Oxford 2005; 455-495.
4. Shirey RS, King KE, Ness PM. Delay hemolytic transfusion reactions. W: Hillyer CD, Silberstein LE, Ness PM, Anderson KC.: Blood Banking and Transfusion Medicine. Churchill Livingstone, Philadelphia 2003: 395-400.
5. rd edition. AABB Press, Bethesda 2007: 57-104.
6. Perkins HA, Payne R, Ferguson J, Wood M. Nonhaemolytic febrile transfusion reactions. Quantitative effects of blood components with emphasis on isoantigenic incompatibility of leukocytes. Vox Sang 1966;11:578-600.
7. Toy P, Popovsky MA, Abraham DM i inni. Transfusion-related acute lung injury: definition and review. Crit Care Med 2005;33:721-726.
8. Reil A, Keller-Stanislawski B, Gunay S, Bux J. Specificities of leucocyte alloantibodies in transfusion-related acute lung injury and results of leucocyte antibody screening of blood donors. Vox Sang 2008; 95(4): 313-317.
9. Bux J, Sachs UJH. The pathogenesis of transfusion-related acute lung injury (TRALI). Br J Haematol 2007; 136:788-799. (Pubitemid 46348408)
10. Dry SM, Bechard KM, Milford EL, Churchill WH, Benjamin RJ.: The pathology of transfusion-related acute lung injury. Am J Clin Pathol 1999;112:216-221 (Pubitemid 30212538)
11. Goldman M, Webert KE, Arnold DM, Freedman J, Hannon J, Blajchman MA; TRALI Consensus Panel.: Proceedings of a consensus conference: towards an understanding of TRALI. Transfus Med Rev 2005;19(1):2-31. (Pubitemid 40248500)
12. Engelfriet CP, Reesink HW i inni. International Forum: Measures to prevent TRALI.: Vox Sang 2007; 92:258-277.
13. Żupańska B, Uhrynowska M, Konopka L. Transfusion-related acute lung injury due to granulocyte-agglutinating antibody in a patient with paroxysmal nocturnal hemoglobinuria. Transfusion. 1999; 39:944-947. (Pubitemid 29439789)
14. Żupańska B, Uhrynowska M, Maślanka i inni. Potransfuzyjna ostra niewydolność oddechowa - groźne, zbyt rzadko rozpoznawane powikłanie poprzetoczeniowe. Pol Merk Lek 2006; 119: 514-518.
15. Żupańska B, Uhrynowska M, Michur H, i inni. Transfusion-related acute lung injury and leucocyte-reacting antibodies. Vox Sang 2007; 93:70-77.
16. rd edition. AABB Press, Bethesda 2007: 105-156.
17. Sampson HA, Munoz-Furlong A, Bock SA i inni.: Symposium on the definition and management of anaphylaxis: summary report. J Allergy Clin Immunol 2005; 115(3):584-591.
18. Vyas GN, Perkins HA, Fudenberg HH. Anaphylactoid transfusion reactions associated with anti-IgA. Lancet 1968;2:312-315
19. Triulzi DJ, Blumberg N, Heal JM. Association of transfusion with postoperative bacterial infection. Crit Rev Clin Lab Sci 1990;28:95-107.
20. Vamvakas EC, Moore SB. Blood transfusion and postoperative septic complications. Transfusion 1994;34:714-727 (Pubitemid 24270119)
21. rd edition. AABB Press, Bethesda 2007; 331-338.
22. rd edition. AABB Press, Bethesda 2007: 251-273.
23. Alvarado-Ramy F., Kuehnert MJ., Alonso-Echanove J., Sledge L., Haley NR., Epstein J., Vostal J., Pearson M.: A multistate cluster of red blood cell transfusion reactions associated with use of a leucocyte reduction filter. Transf Med 2006; 16: 41-48
24. Orton MD, Andres T, Bielski M i inni. Acute pain transfusions reaction : An under recognized adverse transfusion event associated with leucoreduced components (abstract). Blood 2001, 98, 57a.
25. Harris E. Massive transfusion. W: Rutman RC, Miller WV. Rockville, MD.: Transfusion therapy. Aspen Publishers 1981; 289-290.
26. Niles SE, McLaughlin DF, Perkins JG, Wade CE, Li Y, Spinella PC, Holcomb JB. Increased Mortality Associated With the Early Coagulopathy of Trauma in Combat Casualties. J Trauma 2008; 64 (6): 1459-1465
27. Stroncek DF, Leonard K, Eiber G, Malech HL, Gallin JI, Leitman SF. Alloimmunization after granulocyte transfusions. Transfusion 1996;36:1009-1015
28. Araujo F, Sa JJ, Araujo V i inni.: Post-transfusion purpura vs. Heparine-induced thrombocytopenia: differential diagnosis in clinical practice. Transf Med 2000; 10: 321-324.
29. Maślanka K, Żupańska B.: Skaza krwotoczna małopłytkowa- rzadko rozpoznawane późne powikłanie poprzetoczeniowe. Poi Merk Lek 2006; 120: 660-663.
30. Maślanka K, Żupańska B.: Post transfusian purpura and delayed haemolytic transfusion reaction. Transf Med 1995; 3: 281-284.
31. Maślanka K, Żupańska B, Bugajna I, Gronkowska A.: Zespół poprzetoczeniowej skazy małoplytkowej jako nieoczekiwane powikłanie po przetoczeniu krwi w czasie zabiegu operacyjnego lub krwotoku z przewodu pokarmowego. Pol Przegla̧d Chir 1994; 66: 1173-1177.
32. Opelz G, Sengar DP, Mickey MR, Terasaki PI. Effect of blood transfusions on subsequent kidney transplants. Transplant Proc 1973; 5:253-259
33. Brojer E.: Immunomodulacja zależna od transfuzji (TRIM) - realne zjawisko biologiczne udokumentowane w badaniach podstawowych o nieudowodnionej szkodliwości klinicznej. Acta Haematol Pol 2008; 39: 687-696.
34. Blumberg N, Heal JM: Transfusion-Related Immunomodulation.: W: Hillyer CD, Silberstein LE, Ness PM, Anderson KC.: Blood Banking and Transfusion Medicine: Basic Principles and Practice. Churchill Livingstone Elsevier, Philadelphia 2007; 701-712.
35. Vamvakas EC, Blajchman MA. Universal WBC reduction: the case for and against. Transfusion 2001; 41: 691-712.
36. Vamvakas EC, Blajchman MA. Transfusion-related immunomodulation (TRIM): an update. Blood Rev 2007; 21: 327-348.